Emergence of Omentin as a Pleiotropic Adipocytokine

Abstract

“Less is more” – this is becoming the global quote on event of alarming rise in the prevalence of obesity among all age groups. The perspective of adipose tissue as merely a fat depot has changed in recent times. Focus is now being laid on the metabolic and inflammatory functions of the adipose tissue which is modulated through adipocytokines. Adipocytokines have been found to control insulin sensitivity, inflammatory activity, neuroendocrine activity, cardiovascular function, food and water intake, breeding, and bone metabolism. Few of these adipokines play a role in the positive metabolism promoting good health, while few of them pose adverse effects. Omentin is a recently identified novel adipocytokine and it falls under the category of being a good adipokine. Plasma omentin-1 levels are significantly decreased in patients with obesity, insulin resistance, and diabetes that contribute to the major components of the metabolic syndrome and other disease conditions like atherosclerosis, autoimmune disorders etc and that the review focuses on the comprehensive effects of omentin on all the major systems of the body.

Key words

omentin - adipocytokine - metabolism - cardiovascular diseases

• References

• 1 Hamdy O. The role of adipose tissue as an endocrine gland. Curr Diab Rep 2005; 5: 317-319
• 2 Xu YR, Hu P, Jadhao H et al. Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes 2003; (Suppl 1): A1
• 3 Fu M, Gong DW, Damcott C et al. Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the old order amish. Diabetes 2004; 53: 59
• 4 St Jean P, Husueh WC, Mitchell B et al. Association between diabetes, obesity, glucose and insulin levels in the old older amish and SNPs on 1q21–23. Am J Hum Genet 2000; 67: 332-337
• 5 Xiang K, Wang Y, Zheng T et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21–q23 and chromosome 1q21– q24. Diabetes 2004; 53: 228-234
• 6 Fain JN, Sacks HS, Buehrer B et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes 2008; 32: 810-815
• 7 Schaffler A, Neumeier M, Herfarth H et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102
• 8 Komiya T, Tanigawa Y, Hirohashi S. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun 1998; 251: 759-762
• 9 Senolt L, Polanská M, Filková M et al. Vaspin and Omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1410-1411
• 10 Xu L, Zhu GB, Wang L et al. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 2012; 60: 583-586
• 11 Schäffler A, Neumeier M, Herfarth H et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102
• 12 Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2008; 2: 193-196
• 13 Kuperman DA. Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 2005; 116: 305-311
• 14 Ismail SA, Mohamed SA. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br J Dermatol 2012; 167: 436-439
• 15 Xue Y, Jiang L, Cheng Q et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS One 2012; 7: e46740
• 16 Fioravanti L, Simonini A, Cantarini G et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Pediatr Rheumatol Online J 2011; 9: 304
• 17 Kazama K, Usui T, Okada M et al. Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 2012; 686: 116-123
• 18 Yamawaki H, Kuramoto J, Kameshima S et al. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011; 408: 339-343
• 19 Akbarzadeh S, Ghasemi S, Kalantarhormozi M et al. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI. Gynecol Endocrinol 2012; 28: 521-524
• 20 Tan BK, Adya R, Farhatullah S et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008; 57: 801-808
• 21 Tan BK, Adya R, Farhatullah S. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 2010; 59: 3023-3031
• 22 Yang RZ, Lee MJ, Hu H et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. AJP Endo 2006; 290: 1253-1261
• 23 Moreno-Navarretel JM, Ortegal F, Castro A. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity 2011; 19: 1552-1559
• 24 Wurm S, Neumeier M, Weigert J et al. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovascular Diabetology 2007; 6: 7
• 25 Devaraj S, Dasu MR, Park SH et al. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 2009; 52: 1665-1668
• 26 Esteghamati A, Noshad S, Rabizadeh S et al. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial. Regul Pept 2013; 182C: 1-6
• 27 Bingley PJ, Mahon JL, Gale EAM. Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 2008; 31: 146-150
• 28 Tan BK, Pua S, Syed F. Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diabet Med 2008; 25: 1254-1255
• 29 De Souza Batista CM, Yang RZ, Lee MJ et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56: 1655-1661
• 30 Yan P, Li L, Yang M et al. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2011; 92: 368-374
• 31 Yilmaz Y, Yonal O, Kurt R. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol 2011; 46: 91-97
• 32 Wali A, Morin PJ, Hough CD et al. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Lung Cancer 2005; 48: 19-29
• 33 Washimi K, Yokose T, Yamashita M et al. Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells. PLoS One 2012; 7: e39889
• 34 Lago F, Dieguez C, Gomez-Reino J et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007; 3: 716-724
• 35 Zhang YY, Zhou LM. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur J Pharmacol 2012; 12: 947-948
• 36 Fowler JA, Lwin ST, Drake MT et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood 2011; 118: 5872-5882
• 37 Gualillo O, González-Juanatey JR, Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med 2007; 17: 275-283
• 38 Brand K, Page S, Walli AK. Physiological society symposium: impaired endothelial and smooth muscle cell function in oxidative stress. Experimental physiology 1997; 82: 297-304
• 39 Meigs JB, Hu FB, Rifai N et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-1986
• 40 Oishi Y, Wakatsuki T, Nishikado A et al. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis 2000; 11: 77-81
• 41 Zhong X, Li X, Liu F et al. Omentin inhibits TNF-a-induced expression of adhesion molecules in endothelial cells via ERK/NF-KB pathway. Biochemical and Biophysical Research Communications 2012; 425: 401-406
• 42 Maruyama S, Shibata R, Kikuchi R et al. Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J Biol Chem 2012; 287: 408-417
• 43 Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 2002; 13: 444-451
• 44 Shiojima I, Walsh K. Role of Akt Signaling in Vascular Homeostasis and Angiogenesis. Circulation Research 2002; 90: 1243-1250
• 45 Yamawaki H, Tsubaki N, Mukohda M et al. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010; 393: 668-672
• 46 Xie H, Xie PL, Wu XP et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res 2011; 92: 296-306
• 47 Moreno-Navarrete JM, Ortega F, Castro A et al. Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction. Obesity 2011; 19: 1552-1559
• 48 Yoo HJ, Hwang SY, Hong HC et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2012; 10: 103
• 49 Cai RC, Wei L, Di JZ et al. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2009; 89: 381-384
• 50 El-Mesallamy HO, El-Derany MO, Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 2011; 28: 1194-1200
• 51 Zhong X, Zhang HY, Tan H et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011; 32: 873-878
• 52 Shibata R, Ouchi N, Kikuchi R et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011; 219: 811-814
• 53 Saremi A, Asghari M, Ghorbani A. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. Journal of Sports Sciences 2010; 28: 993-998
• 54 Alcelik A, Tosun M, Ozlu MF et al. Serum Levels of Omentin in End-Stage Renal Disease Patients. Kidney Blood Press Res 2012; 35: 511-516
• 55 Shelton RC, Miller AH. Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 2010; 91: 275-299
• 56 Assadi M, Salimipour H, Akbarzadeh S et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS One 2011; 6: e24240
• 57 Brunetti L, Di Nisio C, Recinella L et al. Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides 2011; 32: 1866-1871
• 58 Barker G, Lim R, Georgiou HM et al. Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One 2012; 7: e42943
• 59 Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769
• 60 Takeuchi T, Adachi Y, Ohtsuki Y et al. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 2007; 40: 115-120
• 61 Yoshimura T, Oppenheim J. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 2011; 317: 674-684